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A simple procedure for the extraction from tissues and deter-
mination by gas chromatography of pentasocine was developed . The
mean recovery from brain was 96X .
Tha time- and dose-dependent uptake of pentazocine into the
brain was investigated and correlated with the plasma levels of
the drug. The results showed a rapid entry of pentazocine into
the brain ; peak concentrations in plasma and brain were obtained
at 2 min and 10 min, respectively, after the i.p . administration .
After the injection of a single dose, the ratio, concentration of
pentasocine in plasma/concentration of pentazocine in brain was
constant from 10-90 min . This ratio remained unchanged over the
range of 25-100 mg/kg of administered drug .
After the observation that pentazocine (1,2,3,4,5,6-hexahydro-6,
11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol), a bensomorphan (BPQ
derivative sae a strong analgesic (1), a number of other compounds with similar
chemical structures were prepared (2,3) and subjected to pharnscological and
clinical evaluation (4,5,6,7) . Pentazocine (1,2,3,4,5,6-hexahydro-6,11-
dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol), a clinically
used BM derivative has been reported to be a potent analgesic in man, with low
incidence of adverse effects (8) and minis~um addiction liability (4,5) . The
distribution of cyclasocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-cyclopropyl-
methyl-2,6-methano-3-benzasocin-8-ol), another BM derivative and pentazocine
has been studied in dogs and cats using the tritiated drugs (9,10) . In these
experiments radioactivity in the brain was higher than in blood or plasma
suggesting an easy penetration of the drugs through the blood-brain barrier .
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However, no identification of the radioactivity was made .
The present investigation was undertaken to study the entry of pentazocine
into the brain of rats and correlate its concentration in this organ with that
in plasma . Existing methods of determination of pentazocine (11,12) do not
include estimation of the drug from tissues . Therefore, a procedure was devel-
oped for the extraction of pentazocine from brain and its quantitation by gas
chromatography .
Experimental Procedure
Pentazocine and cyclasocine were supplied as barns .
prepared in 0.9X NaCl by adjusting the pH to 4 with HC1 .
ae the internal standard in the
used were of analytical reagent
Male Sprague-Dowley rata weighing 300 g
experiments seven groups of four rate each were injected i.p . (1 ml) with
50 mg/kg pentazocine in 0.9X NaCl, The rats in the individual groups were
decapitated at 2, 5, 10, 30, 60, 90 and 150 min after administration of the
drug . Ten min prior to decapitation, heparin, 0 .15 ml of 1 mg/ml solution in
0 .9X NaCl was administered, i.p . to all animals . The rate sacrificed at 2 and
5 min received heparin 8 and 5 min prior to the administration of the drug,
whereas those decapitated at 10 min received pentazocine
neouely by separate injections . The blood was collected
the brain (excluding the cerebellum) was immediately removed, quickly rinsed in
cold 0.9X NaCI, blotted dry and stored at -20°C . The separated plasma was
at -20°C until analysis .
In the second set of experiments, four groups of four rats were infected
i .p . (1 ml) with 25, 50, 75 and 100 mg/kg pentazocine respectively . These
animals were decapitated at 60 min after the administration of the drug . The
further treatment of the animals ae well ae the sampling of plasma and brain
were as described before .
Stock solutions were
Cyclezocine was used
gas chromatographic procedure . Tha chemicals
grade.
were used, In the first set of
and heparin aimulta-
into centrifuge Cuban ;
kept
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Pentazocine in plasma was analyzed according to the gee chromatographic
procedure developed for the determination of BM derivatives in humsn plasma (13)
The brain was homogenized with 0 .1 N HC1 (10 ml/g tissue) in a Potter-
Elvehjem all-glass homogenizes . The homogenate was centrifuged at 9000 x g for
LO min and the supernatant was collected . The sediment was suspended in 5 ml
of 0.1 N HC1, centrifuged and the supernatant was added to that previously
collected . Cyclazocine, used ae internal standard, was added (0.2 ml of
100 F+g/ml) to 12 ml of the acidic extract . After adjustment of the pH to 8
with 0.5 ml of 1 N NaOH, the drug was extracted with 20 ml benzene for 10 min
on a horizontal shaker at medium speed . The samples then were centrifuged at
1900 x g for 20 min . Fifteen ml of the organic layer was transferred to coni-
cal tubes and evaporated to dryness on a water bath at 65°C under a stream of
nitrogen . Just prior to analysis the residue was dissolved in 50 ~1 acetone
and 1-2 ~1 injected into the gee chromstograph .
The amount of pentazocine in a sample was determined by measuring the
ratio, peak height of ttie drug/peak height of internal standard, and relating
this ratio to previously constructed standard curves obtained by using rat
plasma and rat brain, respectively . These standard curves were linear over a
wide range (25 to 500 ng) . A dual column gas chromatogramh (Hewlett-Packard,
Modal 402) equipped with flame ionization detectors was used . Glass columns
6 feet Long, 1/4 inch O.D . were packed with 3i OV-1 gee chrom Q (100/120 mesh) .
The columns were conditioned for 48 hours et 260°C . Operating conditions were ;
column temperature 210°C, injection port 250°C and flame detector 260°C .
Nitrogen flow was 35 ml/min ; hydrogen and air was adjusted to give optimum
detector response .
Results
Typical chromatograms of pentazocine extracted from plasma and brain after
the i .p . administration to rata are shown in Fig . 1 . The retention time Eor
the internal standard (cyclasocine) was 5 .0 min and for pentazocine 5.7 min .
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Gas chromatographic separation of A: 60 ng of cyclazocine and
240 ng of pentazocine from rat plasma and B : 100 ng of cycla-
socine and 300 ng pentazocine from rat brain homogenate, after
the i.p. administration of pentazocine .
Table 1 shows the recovery of pentazocine from plasma and brain of rats .
In thaee experiments known amounts of pentazocine (2 to 16 y.g/ml plasma or
4 .98 to 38.46 ~g/g brain tissue) were added to plasma or brain homogenate of
untreated rata and tha drug extracted ae described . The mean recovery of
pentazocine from plasma and brain was 100 and 96x, respectively .
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TABLE z
Satovery of panlasotina from rat plasma and rat brain hooog-
eaata. The results represent the mean ± S .D . of 4 rats,
the figures in parenthesis e>press x recovery of the drug .
Aswunt of drug added Amount recovered
The concentration of pentsaocine in plasma and brain of rats after an
i.p, dote of 50 og/kg is shorn in Fig. 2. The plasma concentration dropped
rapidly from 10.18 Rg/ml at 2 min to 2.92 ~,g/ml at 10 min after the adminis
tration. During this time the concentration of the drug in the brain rose
from 3.50 I+g/g to 11.92 4+g/g, At all times the concentration of the drug in
brain nas higher than in plates, 1hn mean ratio, concentration in plasma/
concentration in brain (P/B) of 0.24 reached at 10 min, ores maintained until







from plasma from brain
homogenate
2 4.98 1.96 ± 0.12 (98) 4.68 ± 0.42 (94)
4 9.90 4.12 ± 0.31 (103) 9 .75 ± 1 .01 (98)
8 19 .61 7.96 ± 0.26 (99) 18.14 ± 1.96 (92)
16 38.46 16.36 ± 0.41 (102) 38.20 ± 2.21 (99)
Mean ; 100x 96x
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FIG . 2
Concentration of pentazocine in plasma (H) and brain (e-D)
of rats at various times after the i .p . administration of
50 mg/kg of the drug. 8ach point ie the mean _+ S.D . of 4 rats .
The S.D, at 2 and 5 min has been omitted for clarity . Tha
broken line (0---0) shags the ratio, concentration of drug in
plasma/concentration of drug in brain.
Fig . 3 shoos the concentration of pentazocine in plasma and brain of rats
at 60 min after the i .p . administration of 25, 50, 75 and 100 mg/kg. With
increase of dose, the drug concentration in plasma and brain rose proportlon-
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ately resulting in a constant mean P/B ratio of 0.28 .
In control experiasnts, rats received 0.15 ml of 0.9x NaCl, instead of
heparin, and subsequently the concentration of pantazocine in brain vas
determined . The results agreed vall with those obtained after the administra
tion of the corresponding doses of pantasocine to haparinizad rats .
FIG. 3
Concentration of pentazocina in plasau (B--") and brain (o-D)
of rats at 60 min after the i.p . adainistration of increasing
doses of the drug . Bach point is the mesa ± S.D. of 4 rats .
1be broken line (0---0) shout the ratio, concentration of drug
in plasms/concentration of drug in brain .
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Discussion
The previously reported tissue levels of pentazocine were obtained by the
use of the radioactively labeled drug (10, 14) . The simple procedure for the
determination of pentazocine in brain described in this communication allows
the quantitation of the drug by gas chromatography . Good chromatographic
separation of the internal standard and of pentazocine was achieved, and no
interfering peaks were obtained from the biological material (Fig . 1) . The
high recovery of the drug from brain homogenates (Table 1) suggest the appli-
cability of the procedure to other tissues as well . In combination with the
described gas chromatographic determination of other benzomorphine derivatives
(13) the procedure presented here could be used for the analyaie of these
compounds in tissues .
The analyaie of plasma and brain after the addition of known amounts of
pentazocine, as well as after the i .p . administration of the drug to rata,
yielded identical chromatograms both showing single well resolved peaks with
a retention time of 5.7 minutes. No interference by peaks having similar
retention times was encountered . Pentazocine is mainly metabolized by oxida-
tion of the terminal methyl groups of the dimethylallyl side-chain to yield
two isomeric alcohola . The relative retention times of these metabolites as
compared to pentazocine (1.00) were determined to be 2.06 and 2.30 respective-
ly (14) .
In agreement with the rapid onset of action observed clinically (11) the
concentration of pentazocine in brain reached a high level quickly : peak
levels were obtained LO min after the i.p . administration of the drug
(Fig. 2) . Pentazocine also leaves the brain rapidly : at 60 min after the
administration, the level in brain represented Less than 25X of the peak
concentration . After 60 min the decline was considerably slower . The peak of
plasma levels obtained at 2 min after administration rapidly declined at
60 min to lOx of its original value. Of particular interest was the finding
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that during these rapid and largo changes in concentration of the drug, the
P/B ratio resriaed essentially constant from 10 min to 90 min after the
adsinistration . ltie constancy of the blood/tissue ratio was even more
accentuated in the exparinants when increasing doses of pentasocine were
injected i.p. .: over the range of 25-100 mg/kg, the P/B ratio remained unchang-
ed . Therefore, plasma levels are apparently indicative of the concentration
of pentazocina in the brain .
1ha results presented in this cossunication show that pentasocina with
a salecular weight of 285 obviously penetrates biological membranes quite
easily and the blood/brain barrier seesu to have little restricting effect
on the entry of this coupound into the brain. Pantasocine as a basic amine
is likely to concentrate in tissues, and its high partition coefficient
between organic and aqueous phase (10) esQhasisas its lipophilic nature. How-
ever, the present study daswnatratas a pronounced and rapid exchange of the
drug between compartments separated by biological seubranes and justifies
further work to elucidate the oachaniss of this transport. Such work is in
progress .
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